Skip to content

Ambu Aura-i and Air-Q Intubating Laryngeal Airways as a Conduit for Tracheal Intubation in Children

Prospective Randomized Comparison of the Ambu Aura-i and Air-Q Intubating Laryngeal Airways as a Conduit for Tracheal Intubation in Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01535742
Enrollment
120
Registered
2012-02-20
Start date
2012-02-29
Completion date
2012-04-30
Last updated
2012-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheal Intubation in Children

Keywords

laryngeal mask airway, children, tracheal intubation, fiberoptic bronchoscopy

Brief summary

The purpose of this study is to determine whether there is a clinically relevant difference in time to tracheal intubation when using fiberoptic bronchoscope as a guide to intubate through the Ambu Aura-i or air-Q ILA.

Detailed description

The goal of this prospective randomized study is to compare the Ambu Aura-i and air-Q ILA in children with normal airway anatomy, in order to evaluate the effectiveness of fiberoptic tracheal intubation through these two devices. The ease of placement, fiberoptic grade of laryngeal view, time to tracheal intubation, time for device removal after intubation, and peri-operative complications will also be assessed.

Interventions

DEVICEAmbu Aura-i size 1.5

Device will be placed and fiberoptic tracheal intubation will be performed and timed. Laryngeal grade of view will also be assessed

DEVICEair-Q ILA size 1.5

Device will be placed and fiberoptic tracheal intubation will be performed and timed. Laryngeal grade of view will also be assessed

DEVICEAmbu Aura-i size 2

Device will be placed and fiberoptic tracheal intubation will be performed and timed. Laryngeal grade of view will also be assessed

DEVICEair-Q ILA size 2

Device will be placed and fiberoptic tracheal intubation will be performed and timed. Laryngeal grade of view will also be assessed

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
1 Months to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Children undergoing general anesthesia requiring tracheal intubation * Weight 5-20 kg * Age one month-six years

Exclusion criteria

* ASA class IV, V Emergency procedures * History of a difficult airway * Active upper respiratory tract infection * Children receiving emergent surgery

Design outcomes

Primary

MeasureTime frameDescription
Ease and time to successful tracheal intubationparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursfrom the time of fiberoptic bronchoscope entry into the device until positive clinical signs indicating successful tracheal intubation (i.e., presence of bilateral breath sounds, appropriate end-tidal CO2) are confirmed

Secondary

MeasureTime frameDescription
Number of attempts to place the supraglottic device and tracheal tubeparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursnumber of attempts needed for successful placement will be recorded (maximum of 3 attempts; \>3 attempts will be considered as a failure)
Airway Leak Pressureparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursAirway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed completely
Fiberoptic grade of laryngeal viewparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe laryngeal alignment through the devices will be graded using an established scoring system
Ease and time to place airwayparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursFrom picking up the airway device to bilateral chest expansion and presence of ETCO2
Airway maneuversparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe number and type of various airway maneuvers such as jaw thrust, neck extension, advancement/ withdrawal of the supraglottic device, and/ or anterior Laryngeal Pressure to optimize tracheal intubation will be recorded
Adverse effectsParticipants will be followed for the duration of anesthesia and 24 hours postoperativelycomplications such as oxygen desaturations, inadvertent extubation, tracheal pilot balloon breakage, mucosal trauma, reflex activation of the airway, sore throat, dysphonia will be recorded
Time to remove deviceparticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursremoval will be done with the use of a removal stylet. Should inadvertent extubation occur during removal of the device, the intubation will be deemed a failure.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026